[HTML][HTML] Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?
KN van Munster, A Bergquist, CY Ponsioen - Journal of Hepatology, 2023 - Elsevier
Primary sclerosing cholangitis (PSC) was declared one of the biggest unmet needs in
hepatology during ILC 2016 in Berlin. Since then, not much has changed unfortunately …
hepatology during ILC 2016 in Berlin. Since then, not much has changed unfortunately …
The landscape of the methodology in drug repurposing using human genomic data: a systematic review
L Wang, Y Lu, D Li, Y Zhou, L Yu… - Briefings in …, 2024 - academic.oup.com
The process of drug development is expensive and time-consuming. In contrast, drug
repurposing can be introduced to clinical practice more quickly and at a reduced cost. Over …
repurposing can be introduced to clinical practice more quickly and at a reduced cost. Over …
Immunopathogenesis of primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis: themes and concepts
Autoimmune liver diseases (AILDs) include primary biliary cholangitis (PBC), primary
sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH), a family of chronic immune …
sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH), a family of chronic immune …
ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis
J Zhang, H Wang, J Liu, L Fu, S Peng - Human Genomics, 2023 - Springer
Background Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease, with
unclear pathogenesis. Although immune disorders, especially T cell infiltration, are thought …
unclear pathogenesis. Although immune disorders, especially T cell infiltration, are thought …
Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis
L Chen, Y Zhao, M Li, G Lv - Hepatology International, 2024 - Springer
Background Primary sclerosing cholangitis (PSC) is a kind of cholestatic liver disease
without effective therapies and its pathogenesis is largely unknown. Methods We performed …
without effective therapies and its pathogenesis is largely unknown. Methods We performed …
Genetic correlation, shared loci, but no causality between bipolar disorder and inflammatory bowel disease: A genome-wide pleiotropic analysis
BR Wang, J Wang, T Tian, SX Zhang, YQ Zhao… - Journal of Affective …, 2024 - Elsevier
Background and aims The comorbidity between bipolar disorder (BD) and inflammatory
bowel disease (IBD) has been widely reported in observational studies. However, unclear …
bowel disease (IBD) has been widely reported in observational studies. However, unclear …
Primary sclerosing cholangitis causally affects kidney function decline: A Mendelian randomization study
JM Cho, JH Koh, SG Kim, S Lee, Y Kim… - Journal of …, 2024 - Wiley Online Library
Abstract Background and Aim The causal linkage between primary sclerosing cholangitis
(PSC) and kidney function is unexplored despite their potential for long‐term detrimental …
(PSC) and kidney function is unexplored despite their potential for long‐term detrimental …
Role of PAR1 −506 deletion/insertion polymorphism in primary sclerosing cholangitis
B Langhans, S Kalthoff, T Zhou… - Hepatology …, 2024 - Wiley Online Library
Aim Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease characterized by
inflammation of the intra‐and extrahepatic bile ducts. Pathogenesis of PSC is still enigmatic …
inflammation of the intra‐and extrahepatic bile ducts. Pathogenesis of PSC is still enigmatic …
Mendelian randomization‐new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply.
S Massironi, C Viganò… - Alimentary Pharmacology …, 2023 - search.ebscohost.com
Letter: Mendelian randomization ‐ new perspective in inflammatory bowel disease and pancreatic
cancer? Authors' reply Page 1 Aliment Pharmacol Ther. 2023;58:145–146 …
cancer? Authors' reply Page 1 Aliment Pharmacol Ther. 2023;58:145–146 …
Multi-trait genome-wide analysis identified novel risk loci and candidate drugs for heart failure
ZY Yu, M Lin, Z Liang, Y Yang, W Chen, Y Wang… - medRxiv, 2024 - medrxiv.org
Heart failure (HF) is a common cardiovascular disease that poses significant morbidity and
mortality risks. While genome-wide association studies reporting on HF abound, its genetic …
mortality risks. While genome-wide association studies reporting on HF abound, its genetic …